T. Rowe Price Investment Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $300M | Buy |
|
|||||
|
2025
Q2 | $195M | Buy |
|
|||||
|
2025
Q1 | $102M | Sell |
|
|||||
|
2024
Q4 | $234M | Sell |
|
|||||
|
2024
Q3 | $463M | Buy |
|
|||||
|
2024
Q2 | $304M | Buy |
|
|||||
|
2024
Q1 | $243M | Buy |
|
|||||
|
2023
Q4 | $78.3M | Buy |
|
|||||
|
2023
Q3 | $61.4M | Buy |
|
|||||
|
2023
Q2 | $57.1M | Buy |
|
|||||
|
2023
Q1 | $27.5M | Buy |
|
|||||
|
2022
Q4 | $24.5M | Buy |
|